The neuregulins (NRG1–NRG4) are a family of structurally related intercellular signaling proteins, members of the epidermal growth factor class of neurotrophins and ligands for the ErbB family of receptor tyrosine kinases. NRG1 is perhaps the most studied at the biological level because of its genetic involvement in human cancers, cardiac development, and schizophrenia ( 1 Harrison P.J. Law A.J. Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry. 2006; 60: 132-140 Abstract Full Text Full Text PDF PubMed Scopus (376) Google Scholar ). The NRG1 gene maps to 8p21-p12, a chromosomal locus showing evidence of genome-wide linkage to schizophrenia, and common polymorphic variation in NRG1 has been repeatedly associated with increased disease risk ( 1 Harrison P.J. Law A.J. Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry. 2006; 60: 132-140 Abstract Full Text Full Text PDF PubMed Scopus (376) Google Scholar , 2 Stefansson H. Sigurdsson E. Steinthorsdottir V. Bjornsdottir S. Sigmundsson T. Ghosh S. et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002; 71: 877-892 Abstract Full Text Full Text PDF PubMed Scopus (1414) Google Scholar ). Genetic mouse models of NRG1 have revolutionized understanding of the role of NRG1/ErbB signaling in nervous system development and function, revealing that NRG1 is a critical mediator of neuronal and glial cell differentiation, proliferation, and survival as well as a key regulator of myelination, neurotransmitter function, and synaptic plasticity. Despite progress in understanding of the basic neurobiological role of NRG1, ambiguity about the causative molecular basis of involvement of NRG1 in schizophrenia (i.e., gain or loss of function vs. isoform-specific dysregulation) has complicated the development of disease-relevant genetic mouse models. To date, there has been considerable emphasis on the role of NRG1 haploinsufficiency in rodents for the development of cognition and behaviors related to schizophrenia ( 2 Stefansson H. Sigurdsson E. Steinthorsdottir V. Bjornsdottir S. Sigmundsson T. Ghosh S. et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002; 71: 877-892 Abstract Full Text Full Text PDF PubMed Scopus (1414) Google Scholar , 3 O’Tuathaigh C.M. Harte M. O’Leary C. O’Sullivan G.J. Blau C. Lai D. et al. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 ‘knockout’ mice. Eur J Neurosci. 2010; 31: 349-358 Crossref PubMed Scopus (66) Google Scholar ), even though evidence of NRG1 downregulation in schizophrenia is minimal. In comparison, less attention has been paid to the neurobiological effects of increased NRG1 expression and the role of isoform-specific dysregulation, for which evidence of a pathogenic role in schizophrenia is considerable. More recent evidence regarding potential molecular mechanisms of risk at the NRG1 locus in schizophrenia has created a gradual shift from focus on NRG1 haploinsuffiency to the development of more sophisticated, disease-relevant transgenic mouse models of NRG1 isoform dysregulation. Reversible Overexpression of Bace1-Cleaved Neuregulin-1 N-Terminal Fragment Induces Schizophrenia-Like Phenotypes in MiceBiological PsychiatryVol. 76Issue 2PreviewNeuregulin-1 (Nrg1) is a pleiotropic signaling molecule that regulates neural development, and mutation of Nrg1 is a risk factor for schizophrenia. Cleavage of type I β1 Nrg1 isoform by Bace1 releases a secreted N-terminal fragment (Nrg1-ntfβ), which can bind to a cognate ErbB receptor to activate the specific signaling cascade. This study aimed to determine whether increased expression of Nrg1 is beneficial for brain development and functions. Full-Text PDF
Read full abstract